Commentary · 27 May 2023
Mini reviewPublished 28 Sep 2023
Ensuring Data Security and Compliance in Clinical Data Management
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clinical data management is a critical aspect of the healthcare and pharmaceutical industries. It involves the collection, storage, and analysis of vast amounts of patient data, clinical trial results, and other healthcare-related information. The importance of data in this field cannot be overstated, as it plays a crucial role in drug development, patient care, and medical research. However, with great data comes great responsibility. Ensuring data security and compliance in clinical data management is paramount to protect patient privacy, maintain data integrity, and meet regulatory requirements. In this comprehensive guide, we will delve into the various aspects of data security and compliance in clinical data management. Before we dive into the specifics of data security and compliance, it's essential to understand why clinical data management is so significant. Clinical data management encompasses a wide range of activities, including. Data security in clinical data management refers to the practices and measures put in place to protect data from unauthorized access, data breaches, and other security threats. Here are some key components of data security in this context.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 26 Jun 2024
Overcoming Challenges: Ensuring Data Privacy and Security in AI-Driven Pharma
Conference abstract · 11 Sep 2017
Substantial data for faster clinical trial approval with compliance meds technologies clever cap
Conference abstract · 11 Sep 2017
Substantial Data for Faster Clinical Trial Approval with Compliance Meds Technologies’ CleverCap
Case report · 2017
A Case Study of Clinical Endpoint Bioequivalence Study with Missing Data and Non-compliance Data
More from this journal
The newest in Pharmacoeconomics: Open Access.
Opinion · 1 Dec 2025
Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Walter Kalker”

